Relationship of recipient age and development of chronic allograft failure

Transplantation

Volumn 70, Issue 2, 2000, Pages 306-310

  Meier Kriesche, Herwig Ulf ^a   Akinlolu O, Ojo ^a   Cibrik, Diane M ^a   Hanson, Julie A ^a   Leichtman, Alan B ^a   Magee, John C ^a   Port, Friedrich K ^a   Kaplan, Bruce ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; AGE; AGED; ARTICLE; GRAFT FAILURE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0343628707     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200007270-00012     Document Type: Article

References (27)

1. Jassal SV, Opelz G, Cole E. Transplantation in the elderly: a review. Geriatr.Nephrol Urol. 1997; 7: 157.
2. Tommasi GV, Arcuri V, Beatini M, et al. Renal transplantation in patients over 60 years of age. An increasing clinical reality. Minerva.Urol.Nefrol. 1997; 49: 29.
3. Becker BN, Ismail N, Becker YT, MacDonnell RC, Helderman JH. Renal transplantation in the older end stage renal disease patient. Semin.Nephrol 1996; 16: 353.
4. Schaubel D, Desmeules M, Mao Y, Jeffery J, Fenton S. Survival experience among elderly end-stage renal disease patients. A controlled comparison of transplantation and dialysis. Transplantation 1995; 60: 1389.
5. Hestin D, Frimat L, Hubert J, Renoult E, Huu TC, Kessler M. Renal transplantation in patients over sixty years of age. Clin Nephrol 1994; 42: 232.
6. Ismail N. Renal replacement therapy in the elderly: an old problem with young solutions. Nephrol Dial.Transplant 1997; 12: 873.
7. U.S. Renal Data System, USRDS 1999 Annual Data Report. Bethesda, MD: The National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
8. Paul LC. Chronic allograft nephropathy: an update. Kidney Int 1999; 56: 783.
9. Paul LC. Chronic renal transplant loss. Kidney Int 1995; 47: 1491.
10. Monaco AP, Burke JFJ, Ferguson RM, et al. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis. 1999; 33: 150-160.
11. Pirsch JD, D'Alessandro Am, Sollinger HW, Hoffmann RM, Roecker E, Voss BJ, Lorentzen D, Knechtle SJ, Reed A, Kalayoglu M. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53: 55.
12. Ismail N, Hakim RM, Helderman JH. Renal replacement therapies in the elderly: Part II. Renal transplantation. Am J Kidney Dis. 1994; 23: 1.
13. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Renal transplantation in older people. Lancet 1994; 2: 461.
14. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: the concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167.
15. Nakatsuji S, Yamate J, Sakuma S. Macrophages, myofibroblasts, and extracellular matrix accumulation in interstitial fibrosis of chronic progressive nephropathy in aged rats. Vet Pathol 1998; 35: 352.
16. Thomas SE, Anderson S, Gordon KL, Oyama TT, Shankland SJ, Johnson RJ. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J Am Soc Nephrol 1998; 9: 231.
17. Greenfeld Z, Stillman IE, Brezis M, Rosen S. Medullary injury in the ageing rat kidney: functional-morphometric correlations. Eur J Clin Invest 1997; 27: 346.
18. Takeda T, Imada A, Horiuchi A, Kimura M, Maekura S, Hashimoto S. Age-related changes in morphological studies in rat and human kidney. Nippon.Jinzo.Gakkai.Shi. 1996; 38: 555.
19. Gorczynski RM, Cinader B, Ramakrishna V, Terzioglu E, Waelli T, Westphal O. An antibody specific for interleukin-6 reverses age-associated changes in spontaneous and induced cytokine production in mice. Immunology 1997; 92: 20.
20. Nakamura T, Fox-Robichaud A, Kikkawa R, et al. Transcription factors and age-related decline in apolipoprotein A-I expression. J.Lipid Res. 1999; 40: 1709.
21. Rea IM, McNerlan SE, Alexander HD. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 1999; 34: 79.
22. Straub RH, Konecna L, Hrach S, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: possible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998; 83: 2012.
23. Chiang AN, Chang CP, Chou YC, Huang KY, Hu HH. Differential distribution of apolipoprotein E in young and aged spontaneously hypertensive and stroke-prone rats. J Hypertens 1999; 17: 793.
24. Herrmann W, Quast S, Ullrich M, Schultze H, Bodis M, Geisel J. Hyperhomocysteinemia in high-aged subjects: relation of B-vitamins, folic acid, renal function and the methylenetetrahydrofolate reductase mutation. Atherosclerosis 1999; 144: 91.
25. Janssen JA, Stolk RP, Pols HA, Grobbee DE, Lamberts SW. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol 1998; 18: 277.
26. Abrass CK, Adcox MJ, Raugi GJ. Aging-associated changes in renal extracellular matrix. Am J Pathol 1995; 146: 742.
27. Ruiz-Torres MP, Bosch RJ, O'Valle F, et al. Age-related increase in expression of TGF-betal in the rat kidney: relationship to morphologic changes. J Am Soc Nephrol 1998; 9: 782.